🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "focused measures to tackle cost of living issues" in the forthcoming Budget.

Speaking to the BBC, she stated that curbing inflation is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this year and next.

Possible Utility Bill Measures

It is understood the administration could take action to bring down utility costs, such as by slashing the current 5% level of value-added tax charged on energy.

Another option is to cut some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to declare higher taxes or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on Thursday, estimates indicated there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of projections.

"There's a shared job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor told reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on expected tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing international and trade tensions for the Budget revenue measures, probably to be directed on those "with the broadest shoulders."

Global Trade Tensions

Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "Our security interests invariably come first."

Recent declaration by China to increase trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led American leader Donald Trump to propose an additional 100% tariff on goods from the Asian country, raising the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief labeled the Chinese move "economic coercion" and "a global supply chain control attempt."

Inquired about accepting the American proposal to participate in its conflict with China, Reeves said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "harmful for the world economy and causes further obstacles."

"I believe there are sectors where we must confront Chinese policies, but there are also important prospects to sell into Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance correct."

The Treasury chief also affirmed she was working with G7 counterparts "on our own essential resources strategy, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also admitted that the price the National Health Service pays for drugs could rise as a result of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning investments in the United Kingdom, with several attributing the low prices they are getting.

Last month, the government science advisor said the cost the NHS pays for medicines would have to rise to prevent companies and drug research funding departing from the United Kingdom.

Reeves stated to the BBC: "It has been observed because of the cost structure, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other European countries."

"Our aim is to ensure that individuals getting care from the National Health Service are can access the finest life-saving medicines in the globe. And so we are looking at all of that, and... looking to obtain increased investment into Britain."